Bloomberg Law
Nov. 30, 2017, 8:44 PM

Lawmakers Open to New Ideas to Spur Drug, Device Innovation

Jeannie Baumann
Jeannie Baumann

Members of a key House panel indicated they’re open to additional legislative action if necessary to speed new medicines to patients.

Rep. Michael C. Burgess (R-Texas), chairman of the Energy and Commerce health subcommittee, and Rep. Diana DeGette (D-Colo.) made their remarks exactly one year after the House passed 21st Century Cures, a broad biomedical research bill to spur new drugs and devices. The Cures bill became law Dec. 13, 2016 (Pub. L. 114-255), and Burgess’s subcommittee heard Nov. 30 from the heads of the National Institutes of Health and the Food and Drug Administration on how the ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.